scholarly journals Re: “Timing of Gestational Diabetes Diagnosis by Maternal Obesity Status: Impact on Gestational Weight Gain in a Diverse Population” by Hillier et al.

2020 ◽  
Vol 29 (9) ◽  
pp. 1234-1234
Author(s):  
Marie Monlun ◽  
Ninon Foussard ◽  
Laurence Blanco ◽  
Kamel Mohammedi ◽  
Vincent Rigalleau
Keyword(s):  
Weight Gain ◽  
Gestational Diabetes ◽  
Gestational Weight Gain ◽  
Maternal Obesity ◽  
Diabetes Diagnosis ◽  
Diverse Population ◽  
Gestational Weight ◽  
Obesity Status

scholarly journals Timing of Gestational Diabetes Diagnosis by Maternal Obesity Status: Impact on Gestational Weight Gain in a Diverse Population

2020 ◽  
Vol 29 (8) ◽  
pp. 1068-1076 ◽  
Author(s):  
Teresa A. Hillier ◽  
Keith K. Ogasawara ◽  
Kathryn L. Pedula ◽  
Kimberly K. Vesco ◽  
Caryn E.S. Oshiro ◽  
...  
Keyword(s):  
Weight Gain ◽  
Gestational Diabetes ◽  
Gestational Weight Gain ◽  
Maternal Obesity ◽  
Diabetes Diagnosis ◽  
Diverse Population ◽  
Gestational Weight ◽  
Obesity Status

scholarly journals Relative Contribution of Gestational Weight Gain, Gestational Diabetes, and Maternal Obesity to Neonatal Fat Mass

Nutrients ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3434
Author(s):  
Delphine Mitanchez ◽  
Sophie Jacqueminet ◽  
Said Lebbah ◽  
Marc Dommergues ◽  
David Hajage ◽  
...  
Keyword(s):  
Weight Gain ◽  
Gestational Diabetes ◽  
Gestational Weight Gain ◽  
Body Fat ◽  
Dietary Intervention ◽  
Maternal Obesity ◽  
Secondary Analysis ◽  
Third Trimester ◽  
Gestational Weight ◽  
Relative Contribution

Maternal nutritional and metabolic status influence fetal growth. This study investigated the contribution of gestational weight gain (GWG), gestational diabetes (GDM), and maternal obesity to birthweight and newborn body fat. It is a secondary analysis of a prospective study including 204 women with a pregestational body mass index (BMI) of 18.5–24.9 kg/m2 and 219 women with BMI ≥ 30 kg/m2. GDM was screened in the second and third trimester and was treated by dietary intervention, and insulin if required. Maternal obesity had the greatest effect on skinfolds (+1.4 mm) and cord leptin (+3.5 ng/mL), but no effect on birthweight. GWG was associated with increased birthweight and skinfolds thickness, independently from GDM and maternal obesity. There was an interaction between third trimester weight gain and GDM on birthweight and cord leptin, but not with maternal obesity. On average, +1 kg in third trimester was associated with +13 g in birthweight and with +0.64 ng/mL in cord leptin, and a further 32 g and 0.89 ng/mL increase in diabetic mothers, respectively. Maternal obesity is the main contributor to neonatal body fat. There is an independent association between third trimester weight gain, birthweight, and neonatal body fat, enhanced by GDM despite intensive treatment.

scholarly journals Variation in the relationship between gestational diabetes diagnosis and total gestational weight gain by race/ethnicity

2015 ◽  
Vol 108 (1) ◽  
pp. e14-e17 ◽  
Author(s):  
Rosette J. Chakkalakal ◽  
Tebeb Gebretsadik ◽  
Shubhada Jagasia ◽  
Ayumi Shintani ◽  
Tom A. Elasy
Keyword(s):  
Weight Gain ◽  
Gestational Diabetes ◽  
Gestational Weight Gain ◽  
Diabetes Diagnosis ◽  
Gestational Weight ◽  
Race Ethnicity ◽  
The Relationship

Rationale, design, and challenges with implementing a clinical intervention to teach appropriate gestational weight gain (TAGG): Protocol of a Randomized controlled trial (Preprint)

2019 ◽  
Author(s):  
Awathif Mackeen ◽  
Danielle Downs ◽  
Vonda Hetherington ◽  
Shawnee Lutcher ◽  
Jacob Mowery ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Weight Gain ◽  
Gestational Diabetes ◽  
Usual Care ◽  
Gestational Weight Gain ◽  
Perceived Stress ◽  
Controlled Trial ◽  
Household Food Security ◽  
Gestational Weight ◽  
Randomized Controlled

BACKGROUND Excessive gestational weight gain (GWG) has public health implications including preterm birth, preeclampsia, gestational diabetes, and cesarean delivery. In an effort to mitigate adverse consequences of excessive GWG, this study tests a health intervention that includes enhancements to improve knowledge and awareness of appropriate GWG, and patient-centered nutritional counseling to promote appropriate GWG. OBJECTIVE The primary objective of the study was to increase the proportion of women who are managing their GWG as recommended by the IOM.4,5 METHODS This randomized controlled trial was conducted at Geisinger in Pennsylvania where excessive GWG is common among women with pre-conception obesity. Eligible, consenting participants with pre-pregnancy body mass index >30.0 kg/m2 were randomized (1:1) to: 1) Usual Care: usual written educational materials and counseling by an obstetric care provider or 2) Enhanced Care: Usual Care plus a) a personalized letter from a physician detailing appropriate GWG, b) exposure to individualized GWG chart in the electronic health record via the patient portal, and c) a consult with a Registered Dietitian Nutritionist and follow-up via tele-health counseling (10-20 mins/1-2 weeks) for the duration of the pregnancy. RESULTS The primary outcome was the proportion of women that gain less than 20 pounds over the course of the pregnancy. Secondary outcomes include knowledge, expectations, and attitude about pregnancy weight gain; increased self-efficacy for ability to eat healthy and being physically active to manage weight; and eating behavior. Potential moderators that will be explored include sleep, perceived stress, perceived involvement in care, and household food security. Data collection has been completed as of November 2019. CONCLUSIONS As GWG care was initiated for mothers with pre-pregnancy BMI >30 kg/m2 within the first and second trimesters, the intervention may have the additional benefit of reducing other adverse pregnancy outcomes including the incidence of gestational diabetes due to healthier rates of GWG. In addition to assessing appropriate GWG, this project will assess eating habits, physical activity, GWG attitudes, sleep quality, and psychological measures, all of which are associated with GWG. Exploratory mediators including perceived stress and food insecurity will also be evaluated. CLINICALTRIAL ClinicalTrials.gov NCT02963428

1100 Impact of gestational weight gain in women with chronic hypertension and pre-gestational diabetes

2021 ◽  
Vol 224 (2) ◽  
pp. S678
Author(s):  
Grace J. Johnson ◽  
Haleh Sangi-Haghpeykar ◽  
Kjersti M. Aagaard ◽  
Alison N. Goulding ◽  
Matthew A. Shanahan ◽  
...  
Keyword(s):  
Weight Gain ◽  
Gestational Diabetes ◽  
Gestational Weight Gain ◽  
Chronic Hypertension ◽  
Gestational Weight

scholarly journals Paternal and maternal obesity but not gestational weight gain is associated with type 1 diabetes

2018 ◽  
Vol 47 (2) ◽  
pp. 417-426 ◽  
Author(s):  
Maria C Magnus ◽  
Sjurdur F Olsen ◽  
Charlotta Granstrom ◽  
Nicolai A Lund-Blix ◽  
Jannet Svensson ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Weight Gain ◽  
Gestational Weight Gain ◽  
Maternal Obesity ◽  
Gestational Weight

scholarly journals Association between Gestational Weight Gain, Gestational Diabetes Risk, and Obstetric Outcomes: A Randomized Controlled Trial Post Hoc Analysis

Nutrients ◽  
2018 ◽  
Vol 10 (11) ◽  
pp. 1568 ◽  
Author(s):  
David Simmons ◽  
Roland Devlieger ◽  
Andre van Assche ◽  
Sander Galjaard ◽  
Rosa Corcoy ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Weight Gain ◽  
Gestational Diabetes ◽  
Gestational Weight Gain ◽  
First Trimester ◽  
Obstetric Outcomes ◽  
Lifestyle Interventions ◽  
Gestational Weight ◽  
Randomized Controlled ◽  
Post Hoc

Excess gestational weight gain (GWG) is associated with the development of gestational diabetes mellitus (GDM). Lifestyle trials have not achieved much GWG limitation, and have largely failed to prevent GDM. We compared the effect of substantial GWG limitation on maternal GDM risk. Pregnant women with a body mass index (BMI) ≥29 kg/m2 <20 weeks gestation without GDM (n = 436) were randomized, in a multicenter trial, to usual care (UC), healthy eating (HE), physical activity (PA), or HE and PA lifestyle interventions. GWG over the median was associated with higher homeostasis model assessment insulin resistance (HOMA-IR) and insulin secretion (Stumvoll phases 1 and 2), a higher fasting plasma glucose (FPG) at 24–28 weeks (4.66 ± 0.43 vs. 4.61 ± 0.40 mmol/L, p < 0.01), and a higher rate of caesarean section (38% vs. 27% p < 0.05). The GWG over the median at 35–37 weeks was associated with a higher rate of macrosomia (25% vs. 16%, p < 0.05). A post hoc comparison among women from the five sites with a GWG difference >3 kg showed no significance difference in glycaemia or insulin resistance between HE and PA, and UC. We conclude that preventing even substantial increases in GWG after the first trimester has little effect on maternal glycaemia. We recommend randomized controlled trials of effective lifestyle interventions, starting in or before the first trimester.

Sign in / Sign up

Export Citation Format

Share Document